Plain-English translation of NCT06243614 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new medication called Buagafuran to see if it can help people with generalized anxiety disorder (excessive worry that interferes with daily life). Researchers will compare how well this new medication works compared to an existing anxiety medication called Buspirone and compared to a placebo (a fake pill). The goal is to determine whether the medication is safe and actually helps reduce anxiety symptoms.
Generalized anxiety disorder affects many people, but current treatments don't work well for everyone. This trial exists to see if this new medication could be a better option for people struggling with persistent anxiety.
You likely qualify if…
You likely don't qualify if…
If you are accepted, you will visit the clinic for a total of 7 visits over about 10 weeks. You will take capsules twice daily (with breakfast and dinner) for 8 weeks—either the new medication, the comparison medication, or a placebo. Your doctor may adjust your dose during the first month based on how you respond and how well you tolerate the treatment. Researchers will check your anxiety and mood at each visit to see how the treatment is working.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
China
Phase
Large-scale testing
Sponsor
Beijing Union Pharmaceutical Factory Ltd
Collaborators
R&G Pharma Studies Co.,Ltd.
Enrollment target
~410 participants
Started
July 2023
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in February 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tao Sun
Beijing Union Pharmaceutical Factory Ltd
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.